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Tumour microenvironment determines the fate of treatments. Reconstitution of tumour conditions is
mandatory for alternative in vitro methods devoted to cancer development and the selection of thera-
peutic strategies. This work describes a 3D model of melanoma growth in its environment. Introducing
means to mimic tumour angiogenesis, which turns on tumour progression, the model shows that
melanoma tumour spheroids allow reconstitution of solid tumours with stromal cells. Angiogenesis
evidenced the differential recruitment of endothelial cells (EC) from early progenitors (EEPCs) to mature
ECs. Hypoxia was the key parameter that selected and stabilized melanoma cancer stem like cells (CSCs)
phenotype based on aldehyde dehydrogenase expression as the best criterion. The 3D-tumour-model
demonstrated the distinct reactivity of ECs toward tumour cells in terms of cellular cross-talk and hu-
moral response. Intra-spheroid cell-to-cell membrane dye exchanges, mediated by intercellular in-
teractions, uncovered the melanoma-to-EEPC cooperation. The resulting changes in tumour milieu were
evidenced by the chemokinic composition and hypoxia-related variations in microRNA expression
assessed in each cellular component of the spheroids. This method brings new tools to decipher the
molecular mechanism of tumour-mediated cell recruitment and for in vitro assessment of therapeutic
approaches.
© 2017 The Author(s). Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Melanocytes are melanin-producing cells in response to ultra-
violet (UV) radiations. Melanin forms in keratinocytes a photo-
protective cap over the cell nucleus reducing DNA damage [1].hysics, UPR 4301 CNRS Affili-
x 02, France.
Kieda).
Paediatrics, Faculty of Medi-
ielicka 265, 30-663, Krakow,
y, University of Geneva, CH-
er Ireland Ltd. This is an open acceIntense and intermittent exposure of the skin to solar radiation,
without proper protection can damage DNA leading to mutations
and carcinogenesis [2]. Althoughmelanoma represents only 4%of all
skin cancers, it is responsible for the majority (70%) of skin-cancer
related deaths [3]. Melanoma is a strongly metastatic [2], very het-
erogeneous, complexcancerwhich cannotbeproperlystudiedusing
classical in vitro culture methods. Critically important for adequate
evaluation of the effectiveness of a therapy, are alternative in vitro
methods with the ability to properly reproduce as much as possible
the melanoma microenvironment that exists in vivo. Therefore
technologies mimicking the three-dimensional tumour microenvi-
ronment are in great demand. 3D organotypic spheroid cultures in
collagen-derivedmatricesmay be viewed as alternative methods to
validate and improve preclinical strategies [4].ss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
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considerable consequences for treatments. This show the need to
reconstitute such tissue conditions while setting in vitro alternative
methods for application to cancer models in vivo [6]. Hypoxia oc-
curs when a tumour develops. It turns on the angiogenic switch,
stabilizing HIF-1a, the main transcription factor which controls the
production of proangiogenic molecules as VEGFs by tumour cells.
The angiogenic switch operates mainly on the tumour-surrounding
ECs, making sprouting of vicinal vessels and also by recruitment of
EPCs from the bone marrow to specifically reach the hypoxic re-
gions in tumours [7], [8]. However, the tumour micro vessels
remain abnormal and not functional to bring blood, consequently
oxygen, into the tumour mass. This leads to a non-ending proan-
giogenic state which makes pathologic angiogenesis a hallmark of
cancer [9e12].
In melanoma as in other tumours, cancer cells and microenvi-
ronment adapt mutually to optimize growth and invasion condi-
tions by both humoral and cellular responses. Cytokines and
chemokines such as CXCL12 and CCL21 regulate immune cells
recruitment, metastasis [13,14] and angiogenesis [14,15] being key
chemokines for EPCs recruitment and maturation [16,17]. The cell
crosstalk operates by the modulation of adhesion molecules as
selectins and chemokine receptors which interact with the extra-
cellularmatrixmolecules such as podoplanin [18], mediating CCL21
presentation by cancer activated fibroblasts (Tejchman et al.
Oncotarget, in press). This mechanism controls the tumour-cell
movements thus metastatic escape [19,20] and immune cells
recruitment in the tumour site [21].
It should be emphasized that such effects may result from the
upstream dysregulation of the microRNAs (miRs), which are key
gene modulators of the tumour microenvironment balance. The
angiogenesis-controlling MiRs, angiomiRs and hypoxamiRs, are
induced by tumour hypoxia and often promote pathologic vascu-
lature; thus they constitute therapeutic targets [22]. Therefore,
their role in tumour microenvironment is crucial and their pattern
of expression is of potential diagnostic value. MiR expression can be
highly characteristic as miR1246 overexpression in tumour endo-
thelial cells [23].
Tumour angiogenesis takes advantage of the progenitor cells
plasticity both endothelial and tumoural. Cancer stem-like cells
(CSC) were described as mimicking microvascular endothelial cells
and endothelial precursors cells in the tumour niches [24,25]. This
suggests that tumour and endothelial cells interactions occur in
hypoxia as inside tumour niches [26].
In this view, the place and conditions in which CSCs originate as
well as their microenvironment remain controversial. CSCs were
often observed associated with endothelial cells, thus the cancer
stem cell niche was first understood as non-hypoxic although
resistance to hypoxia is a characteristic feature of CSCs [5,27] and
stemness phenotype is stabilized by hypoxia [28].
Acting through the production of factors able to exert a para-
crine chemoattractant effect, CSCs may sensitize endothelial cells,
especially progenitors ECs for recruitment into the tumour site [29].
Consequently, to study in vitro tumour reactivity, the very first
step would be to reconstitute tumour angiogenesis utilizing tools
able to mimic and respond to tumour signals. In the present mel-
anoma tumour model, angiogenesis was achieved by endothelial
progenitors to mimic tumour-recruited ECs while, in the approach
of the metastatic process, lung-derived mature endothelial cells
were used.
Hypoxic conditions are usually reproduced in classical 2D co-
cultures, but the tumour is organized three-dimensionally.
Spheroid structure allows in vitro the normal establishment of
hypoxia along the spheroid structure development [30,31].Taking the selected parameters into account, this work shows
the new possibilities brought by a biologically relevant model for
in vitro cancer studies. Focused on the angiogenic reaction under
hypoxic conditions the 3D model demonstrates interactions of
EEPCs with tumour-cells inside a 3D structure. The profound effects
of hypoxia and tumour angiogenesis reconstructionwere shown by
changes in the humoral composition, especially in microRNA
expression pattern evaluated in each distinct cell component of the
tumour models.
Materials and methods
Details on cell lines, cell culture, co-cultures of melanomawith endothelial cells,
fluorescent labelling of cells, cancer stem-like cells typing by ALDH activity, cloning
for spheroid formation, In vitro pseudo tube formation, HIF-1a production and
estimation, chemokines assessment by ELISA tests, extraction of cells from 3D
tumour models for miRNA analysis, quantitative PCR and statistical analysis are
described in Supplementary Materials and methods.
Spheroid formation
To obtain spheroids from B16-F10 and M10 lines, 1000 cells were mixed with a
0.25% (w/v) methylcellulose (R&D, HSC001) solution in culture medium (30 mL) and
seeded in Perfecta3D® 96-Well Hanging Drop Plates (3D Biomatrix, HDP1096-8).
After 48 h incubation at 37 C in a 5% CO2/95% air atmosphere, a single spheroid
per drop was obtained.
3D cell model of melanoma microenvironment
The matrix is collagen type I (CORNING, #354236) 1.6 mg/mL PBS completed
with FBS (10% v/v), 1.12% of methylcellulose w/v and Matrigel™ 25% (v/v). MAgECs
10.5, MAgECs 11.5 and Lung FVB cells were stained with Lipophilic Tracerse DiI, DiO
and DiD respectively. 5  105 of each EC line was mixed with 50 spheroids inside of
225 mL of cold matrix and put in wells of a 24 well-plate. Control spheroids were
fixed by 4% PFA in PBS (w/v) for 30 min and neutralized by 20 mM urea in PBS, for
30min. Matrix polymerization at 37 C was allowed for 1 h 250 mL of OptiMEMwere
poured gently. The plate was introduced into the incubation chamber of the video
microscope station at 37 C, 5% CO2, and 18.75% O2 (normoxia) or 1% O2 (hypoxia).
Time-lapse acquisitions were performed each hour over 24 h with a Zeiss Axiovert
200M fluorescence inverted microscope (Zeiss).
A human 3D model of melanoma was also prepared in a similar matrix.
HEPC.CB1 cells stained with PKH67, HSkMEC cells stained with DiD and M10 mel-
anoma spheroids were utilized. 5  105 of each EC line was mixed with 50 mela-
noma spheroids inside 225 mL of cold matrix in wells of a 24 well-plate.
3D models with ALDH positive or negative spheroids were prepared by mixing
20 B16F10 ALDHþ or ALDHe spheroids (14 day-cultures after cloning) with 5 105 of
DiI stained MAgECs 11.5 and DiO stained Lung FVB.
Images were analysed by “Image J” software. ECs migrationwas measured based
on fluorescence. The integrated density of fluorescence from each channel (FITC for
DiO and PKH67; DsRED for DiI and PKH26; Cy5 for DiD) was measured in the area
occupied by the spheroids. Changes were expressed as a function of time. The data
were normalized with reference to 100% integrated density value at t ¼ 2 h.
Results
3D cell cultures by spheroid formation
Characterization of the melanoma cells ability to form spheroids
To build a 3D type of melanoma micro-tumour, a perfecta 3D
system was used. Round, compact spheroids from murine (Fig. 1A)
and human (Fig. 1B) melanoma cell lines from 1000 B16F10 and
M10 were formed. After 48 h of culture, spheroids contained 1700
(þ/ 200) cells. Cell organization inside spheroids was visualized
by Apotome (Zeiss Axiovert 200M fluorescence microscope) as a
cohesive layer of M10 cells (Fig. 1C). Moreover the intra spheroid
cell motility was evidenced for M10 cells (Supplementary video
S1).
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.canlet.2017.03.006.
HIF-1a stabilization by hypoxia in the 3D spheroids of melanoma
HIF-1a stabilization is an effect of hypoxia in cells. Hypoxia in-
side spheroids was studied and reported by ELISA assay for HIF-1a
Fig. 1. Characterization of the 3-dimensional cell cultures of murine and human melanoma. Spheroids formed using Perfecta 3D system from 1000 cells of murine B16F10 (A) or
human M10 (B) melanoma after 48 h of culture. (C) Image of the 35 mm slice of M10 melanoma spheroid. (D) Kinetics of HIF-1a production by B16F10 spheroids in normoxia and
hypoxia. Mean þ/ SEM. (E) Kinetics of HIF-1a production by B16F10 cell monolayers. Mean þ/ SEM. (FeI) Chemokine production by co-cultures of B16F10 melanoma cells with
mature and progenitor ECs. Normalized results of ELISA tests for CCL21 (F), CCL27 (G), CXCL12 (H), CCL17 (I). Mean þ/ SEM. * e p < 0.05; ** e p < 0.01; *** e p < 0.001.
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e2012(Fig. 1D). In 48 h old spheroids the concentration of HIF-1a was
similar in normoxia or hypoxia. For longer incubations in hypoxia,
the HIF-1a concentration was stable. HIF-1a lowered in spheroids
grown in normoxia after 48 h (Fig. 1D) as compared to 2D cell
monolayers in hypoxia, where HIF-1a concentration increased then
decreased (Fig. 1E).Chemokines production by the co-cultured melanoma and
endothelial cells, influence of hypoxia
Cell-to-cell crosstalk was investigated in co-cultures of mela-
noma cells and ECs under normoxia and hypoxia. Expressions of
CCL21 (6CKine), CCL27 (CTACK), CXCL12 (SDF-1), CCL17 (TARC), and
CX3CL1 (fractalkine) was measured. CCL21 expression reduced
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e20 13upon co-culture of tumour cells with ECs. The hypoxia increased
CCL21 production mainly with MAgEC11.5 EPC (Fig. 1F). Hypoxia
effect on CCL27 was the opposite (Fig. 1G), consistently reducing
production by tumour cells alone or with ECs for, either adult or
progenitors. This effect was reversed in co-culture with both ECs.
CXCL12 production was enhanced in B16F10 cells and EPCs co-
cultures. The hypoxia effect was weak (Fig. 1H). CCL17 production
was comparable to CXCL12, which is stimulated by co-culture with
EPCs only (Fig. 1I) showing the distinct effects of EPC vs mature
endothelial cells on the melanoma cells. No production of CX3CL1
was detected.Stem like cancer cells selection and phenotype stabilization by
hypoxia in spheroids
2D cultures of melanoma cells contained very low proportions
of CSCs detectable by stemness markers. Fig. 2 shows that CD133
and CD271 are poorly expressed in the B16F10 cells (1% and 0, 5%
respectively) while CD 44 and CD24 were expressed on the total
cell population. None of these antigens was modulated by hypoxia
(Fig. 2A). The influence of pO2 was evidenced in B16F10 cells upon
labelling for ALDH activity (Fig. 2B). The cell population expressing
ALDH reached 18% upon treatment of the cells in hypoxia for 24 h
(Fig. 2C). ALDH activationwas pO2-sensitive (Fig. 2D) and plateaued
after 12 h, in pO2  5% (Fig. 2C). Hypoxia stabilized the stem-like
phenotype (Fig. 2E and F) where the ALDHþ subpopulation coun-
ted for around 15% after 72 h in hypoxia (Fig. 2E). Upon sorting and
keeping the hypoxic conditions the population remained ALDHþ
after 2 weeks in culture (Fig. 2F).
B16F10 cells, sorted for ALDH activity, were used to prepare
spheroids either from 60 sorted tumour cells (Fig. 2GeO) or from
one cloned B16 F10 (Fig. 2P). ALDH spheroids grew faster (Fig. 2G
and K) and formed easier than ALDHþ spheroids (Fig. 2O and P).
However when stromal cells, like EPCs (Fig. 2H and L) or fibroblasts
(Fig. 2I and M), were seeded with tumour cells this effect was
reversed. Less spheroids grew from ALDH cells in the presence of
endothelial progenitors or/and fibroblasts (Fig. 2O and P). The
reduction of ALDH spheroid growth and increase of ALDHþ
spheroid growth were confirmed when both stromal cells were
added (Fig. 2J and N) as shown by the yield of spheroid formation
(Fig. 2O and P).Characterization of angiogenic properties of selected mature and
progenitor ECs
The formation of pseudo-vessels by murine progenitor and
mature ECs was performed in 2D Matrigel (Fig. 3AeC) as mixed
angiogenesis involving EC lines in pairs (Fig. 3DeF) and all together
(Fig. 3G). The same experiments were performed with human
progenitor and mature EC lines (Fig. 3HeN). Images are from
t ¼ 5H. Quantitative analysis of the networks was done using an
Angiogenesis Analyser macro (from Gilles Carpentier Research) for
ImageJ graphic software and presented on graphs (Fig. 3OeV).
Murine EPCs alone did not form pseudo-vessels as opposed to the
numerous, short pseudo-vessels with loops from mature ECs
(Fig. 3AeC, OeR). However EPCs cooperate to form longer but less
pseudo-vessels, than other ECs mixes (Fig. 3F, OeR). Pseudo-vessel
networks were efficiently formed bymixed progenitors andmature
ECs (Fig. 3G). These data were confirmed by angiogenesis achieved
by human endothelial progenitor and mature cells (Fig. 3HeN and
SeV). HEPC.CB1 and HEPC.CB2 alone did not form pseudo vessels
but both progenitors cells cooperate to vessel formation (Fig. 3M,
SeV). Both progenitor cells cooperated with the mature HSkMECs
to produce vessels (Fig. 3KeN). Supplementary video S2 shows that
all EC types cooperated to create stable pseudo-vessels ascompared to individual cell as shown for HSkMECs (Fig. 3N, SeV,
and supplementary video S3).
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.canlet.2017.03.006.
3D model of melanoma microenvironment: ability to recruit
angiogenic endothelial cells and endothelial progenitor cells
To reproduce tumour microenvironment, 3D models of tumour
were composed of murine B16F10 melanoma spheroids which
were placed in the presence of mature and progenitor murine ECs
in collagen/matrigel matrix (Fig. 4AeF).
ECsmigrated toward living B16F10-spheroids in hypoxia (Fig. 4A
and B) and normoxia (Fig. 4D and E) as opposed to fixed B16F10-
spheroids (Fig. 4C and F). As quantified previously [31] and dis-
played here (Fig. 4AeF), ECs recruitment by melanoma spheroids
was higher in hypoxia (Fig. 4B) than in normoxia which displayed
disorganized ECs migration (Fig. 4E). Early endothelial precursor
cell (MAgEC10.5) recruitment was 5 fold higher in hypoxia than in
normoxia while it was twice increased for more mature ECs
(MAgEC11.5 and Lung FVB ECs).
ECs migration was also observed in the human 3D model of
melanoma microenvironment (Fig. 4GeN) in hypoxia compared to
normoxia. Confirming the murine models data [31], human ECs
recruitment was similarly visible only in tumourmodels containing
living melanoma spheroids (Fig. 4GeI, KeM) while no recruitment
occurred in tumour models with fixed cells-containing spheroids
(Fig. 4J and N). Low oxygen tension not only increased ECs migra-
tion toward spheroid (Fig. 4GeI), but also promoted ECs' organi-
zation in a web-like network surrounding the melanoma spheroid
as visible after 24 h (Fig. 4H and supplementary video S4). When
themodels were allowed to develop over 6 days, hypoxia-mediated
recruitment of ECs increased greatly (Fig. 4I and Supplementary
Figure S1). In normoxia, the previously non-organized recruit-
ment of ECs (Fig. 4L) evolved in the long term, into a complex
networkwith cord-like structures surroundingmelanoma spheroid
(Fig. 4M and Supplementary Figure S2) suggesting that hypoxia
appeared in the long-term developing spheroids.
Supplementary data related to this article can be found online at
http://dx.doi.org/10.1016/j.canlet.2017.03.006.
The murine 3D model of melanoma microenvironment was
further utilized to identify the tumour cell population responsible
for ECs recruitment and test the CSCs ability to specifically recruit
EPCs. We compared tumour-spheroids consisting of stem-like
ALDHþ (Fig. 4OeQ) to ALDH cells (Fig. 4ReT) in progenitors
recruitment compared to mature ECs. Quantification is reported on
Fig. 5(AeD).
Recruitment of each EC type by melanoma spheroids in 3D
tumour models could be quantified by ECs fluorescence co-
localization with spheroids. A demonstration that hypoxia specif-
ically increases EPCs recruitment by tumours [31] was extended to
the human tumour model (Fig. 5A and B). Moreover, the recruit-
ment of mature human ECs, decreased in low oxygen tension
(Fig. 5B). Quantification performed for murine 3D tumour models
containing ALDHþ or ALDH melanoma cells (Fig. 5C and D)
showed a great specificity in EPCs recruitment by ALDHþ spheroids
as opposed to ALDH spheroids and compared tomature ECs which
did not display any selectivity.
3D model of melanoma microenvironment: analysis of melanoma-
to-EC intercellular interactions
Melanoma spheroids and recruited ECs were extracted from
the matrix. Cell suspensions obtained from the murine tumour
models were analysed by flow cytometry for their fluorescence
characteristics (Fig. 5EeH). Cells dispersed from spheroids in
hypoxia evidenced the exchange of dye since some cell
Fig. 2. Stem like cancer cells selection and phenotype stabilization by hypoxia in spheroids. (A) CD24, CD44, CD133 and CD271 on B16F10 cells in normoxia and hypoxia. Mean ± SE;
N¼3. (B)Hypoxia activation of ALDH in B16F10 cells assessed byflowcytometry. Gated living cells (P1)withALDEFLUOR (BAAA)displayedALDHactivity inhypoxia (P2). Control level is
given in the presence of DEAB inhibitor of ALDH. (C) Kinetics of ALDH activation as % of BAAA positive cells in normoxia and hypoxia, over 24 h as means ± SE; N ¼ 3; * e p < 0.05. (D)
B16F10 cellswere cultured for 12 hunder pO2¼1%, 5% and 21%;mean± SE;N¼ 3; *ep< 0.05. (E)B16F10 cells incubated 72h in hypoxia andflowcytometryanalysed for ALDHactivity.
(F) Flow cytometry analysis of sorted ALDHþ cells cultured in hypoxia for 2weeks. (GeN) Spheroids formed fromALDH negative 60 sorted cells per well of V-shaped non-adherent 96-
well plate (GeJ) or fromALDHpositive cells (KeN).MAgECs11.5 (H, L),fibroblasts L929 (I,M) or both (J, N)were added in equal proportionskeeping equalfinal number of sorted cells per
well. Imageswere captured after 2weeks,with5objective. (O,P) Yield of spheroid formation fromsortedB16F10 cells. (O) 60 sortedcells perwell and (P) 1 sorted cell perwell.Meanþ/
 SEM. Values significantly different between ALDH and ALDHþ spheroids were marked with: * e p < 0.05; ** e p < 0.01; *** e p < 0.001.
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e2014populations were carrying more than one dye (Fig. 5E). This spe-
cifically occurred in hypoxia as, in normoxia-maintained spher-
oids, the fluorescence of each cell population remained distinct
(Fig. 5F). Tumour-to-ECs interactions were evidenced by the dye-exchange from ECs to non-labelled B16F10 melanoma cells that
acquired fluorescence properties when extracted from 4-days
tumour models (Fig. 5EeH). In hypoxia most of B16F10 cells ac-
quired fluorescence mainly from MAgEC 10.5 and MAgEC 11.5 cells
Fig. 3. Estimation of angiogenic properties and cooperation of mature and progenitor ECs. (AeG) 2D angiogenesis assay for murine ECs alone (AeC), in pairs (DeF) and, all together
(G) eMagEC 10.5 (red), MAgEC 11.5 (green), Lung FVB (not stained). (HeN) Similar angiogenesis assays for human ECs alone (HeJ), in pairs (KeM) and together (N). HEPC. CB1 (red),
HEPC.CB2 (green), HSkMEC (blue). Pictures represent t ¼ 5H. (OeV) Quantitative analysis of angiogenesis performed by murine (OeR) and human (SeV) ECs. Number of nodes (O,
S), pseudo-vessels (P, T), mean length of pseudo-vessels (Q, U) and complete circular capillaries (R, V) were quantified at t ¼ 5H. Mean þ/ SEM. Statistical analysis was performed
using ANOVA analysis and post-hoc Tukey test (HSD).
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e20 15(Fig. 5E and G). In normoxia, no interaction occurred with
MAgEC10.5 or 11.5, showing the specificity of the hypoxia-induced
interactions of tumour cells with early endothelial progenitors,
because in normoxic conditions, dye transfer only occurred with
mature endothelial cells (Fig. 5F and H).3D model of melanoma microenvironment: characterization of the
of microRNAs expression profile
MicroRNAs expression was measured in the whole tumour
model cell populations i.e. B16F10 melanoma and recruited endo-
thelial cells. Hypoxic conditions were compared to normoxia
Fig. 4. Recruitment of ECs by melanoma spheroids inside 3D cell model of melanoma micro-environment. (AeF) Recruitment of MAgECs 10.5 (red), MAgECs 11.5 (green) and Lung
FVB (blue) cells by B16F10 melanoma spheroids in hypoxia (AeC) and normoxia (DeF) after 2 h (A, D) and 24 h (B, E). 3D tumour models with fixed spheroids as negative control at
t ¼ 24H (C, F). (GeN) Recruitment of HEPC.CB1 (green) and HSkMEC (red) cells by M10 melanoma spheroids in hypoxia (GeJ) and normoxia (KeN) after 2 h (G, K), 24 h (H, L) and 6
days (I, M). 3D tumour models with fixed spheroids as negative control at t ¼ 24H (J, N). (OeT) Recruitment of MAgECs 11.5 (red) and Lung FVB cells (green) by B16F10 ALDHþ (OeQ)
and ALDH (ReT) spheroids in hypoxia after 2 h (O, R) and 24 h (P, S). 3D tumour models with fixed spheroids as negative control at t ¼ 24H (Q, T).
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e2016(Fig. 6A) and data validated living spheroids activity (Fig. 6B).
Hypoxia slightly increased the expression of miR-126 and 210-3p,
significantly upregulated miR-21 and greatly increased the pro-
duction of miR-1246 (Fig. 6A). Hypoxia decreased the expression ofmiR-29b compared to normoxia. MiR-21 and 1246 increased in
living spheroid models (Fig. 6B). MicroRNAs expression was also
measured in cells from tumour model after fluorescence-based cell
sorting of each line (Fig. 6CeF).
Fig. 5. Quantification of ECs recruitment in 3D models of melanoma micro-environment and flow cytometry analysis of extracted cells. (A) Recruitment of ECs in human 3D model
of melanoma in hypoxia and normoxia. (B) Effect of hypoxia on ECs recruitment after 24 H. (C) Recruitment of ECs in murine 3D model of tumour containing normal or stem-like
melanoma spheroids in hypoxia. (D) ECs recruitment compared between ALDHþ and ALDH spheroids. Mean þ/ SEM. Values statistically significantly different from T ¼ 2 h (A, C),
between hypoxia and normoxia (B) or ALDHþ and ALDH (D) were marked with: * e p < 0,05; ** e p < 0,01; *** e p < 0,001. (EeH) Flow cytometry analysis of ECs extracted from
murine 3D model of tumour incubated for 4 days in hypoxia (E) or normoxia (F). Interaction between B16F10 melanoma cells and ECs was estimated based on dye exchange in
hypoxia (G) and normoxia (H).
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Fig. 6. microRNA expression in cells extracted from murine 3D model of melanoma micro-environment. (A, B) AngiomiRs expression in extracted mixture of B16F10 and recruited
ECs from tumour model. (A) Effect of hypoxia on miRs production. (B) Comparison of miRs expression between tumour model with living and fixed melanoma spheroids. (CeF) Cells
extracted from spheroids were sorted into separate melanoma and endothelial cell lines. Production of miR-21 (C), miR-29b (D), miR-210-3p (E) and miR-1246 was measured in
comparison to 2D cell cultures in normoxia.
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e2018MiR-21 was efficiently upregulated in 3D models, similarly in
hypoxia and normoxia and this effect concerned the
MAgEC11.5 EPCs andmature Lung FVB ECs (Fig. 6C). The production
of miR-29b was always lower in cells from tumour models and
monolayers in hypoxia than in cells from controls in normoxia.
Downregulation was observed in the tumour model in normoxia
but enhanced by hypoxia in 3D and 2D culture conditions (Fig. 6D).
MiR-210 expression was upregulated in hypoxia only for B16F10
and endothelial lung FVB cells in 2D cultures (Fig. 6E). In tumour
models miR-210 production was increased only in normoxia
(B16F10, MAgEC 11.5 and lung FVB) and decreased in all cells in
hypoxia (Fig. 6E). The expression of miR-1246 greatly increased innormoxia, in all cells of the tumour model, excluding MAgECs 10.5.
MiR-1246 expression was elevated 1000 times by hypoxia in all
cells from tumour model (Fig. 6F) while it was down regulated in
cell lines cultured in 2D in hypoxia.
Discussion
This work shows the advantage of 3D tumour models with
properly defined microenvironment to mimic the tumour devel-
opment in vivo. To-date methods provide only partial information
about tumour development for their inherent limitations in facili-
tating access to variables and parameters relevant of in vivo
K. Klimkiewicz et al. / Cancer Letters 396 (2017) 10e20 19conditions. Consequently, alternative cell culture methods which
permit to get closer to these conditions mimicking 3D growth,
proper oxygen tension, and stromal-to-tumour cell interactions
and communications in tumour microenvironment are of critical
need for cancer research. When a solid tumour develops, the first
step of the stroma establishment occurs with the involvement of
the endothelial cells that are prompted to form vessels by the
angiogenic switch upon hypoxia establishment in the tumour mass
[32]. The aim was to determine the conditions for a 3D cellular
model that would allow investigating the mechanisms of tumour
vascularization taking into account the local vessel sprouting [4]
and elucidating the role of EPCs [31] in pathologic tumour angio-
genesis [33].
The differential role played by mature and progenitor ECs were
shown in vessel formation and in the interactions with tumour
cells. Indeed, cells from a mature endothelial cell line [34] built
vessel-like tubes whereas MAgECs, representative of endothelial
progenitors [31], incorporated into neovessels helping the forma-
tion of pathologic tumour angiogenesis.
This effect was confirmed in a human model showing the active
cooperation between human mature and progenitor endothelial
cells [35,36] to form stable and organized pseudo-vessel network.
The angiogenic switch is the signal for tumour stroma devel-
opment; therefore the effect of a lowoxygen tension onmodulating
the process of tumour vascularization was examined in this 3D
model. The model proved its value to study tumour specific
recruitment signals. Indeed, it enabled us to demonstrate the spe-
cific recruitment of early endothelial progenitor cells (EEPCs) by the
tumour. Moreover, the tumour deep hypoxia was shown to be a
selective pressure for the cancer stem-like cell phenotype. We have
demonstrated that this cell population can be characterized in the
melanoma, by an increased activity of the aldehyde dehydrogenase
e ALDH [37]. These ALDHþ cells are hypoxia-selected and stabi-
lized. In the 3D tumour model, they selectively recruit EEPCs. This
process is specific for only CSCs and hypoxia. Indeed, ALDH cell
spheroids did not recruit EEPCs efficiently even in hypoxia. As CSCs
are the main targets to be reached in cancer treatment [38,39], the
demonstration that endothelial precursors of defined phenotype
are actively attracted into the tumour site by CSCs enhances the
perspectives of new treatment opportunities and of cell-gene
therapy based on EEPC-mediated tumour targeting [31]. Flow
cytometry analyses confirmed that, in hypoxia only, EEPCs inter-
acted closely enough with tumour cells to enable the transfer of
lipophilic fluorescent dyes. Hypoxia-selective recruitment was also
shown using the human 3Dmodel of melanoma, where low oxygen
tension not only increased EPCs recruitment, but also hindered the
recruitment of mature ECs. Thus, the 3D spheroid model of tumour
distinguished the cell mechanism of early endothelial precursor cell
recruitment in the tumour by CSCs showing its potential for
future cellular and molecular information on the cancer
microenvironment-mediated effects. The stromal composition was
completed by the addition of fibroblasts which played a funda-
mental role in helping tumour growth. Not only endothelial pro-
genitors, but also fibroblasts, are important in the creation of a
stable tumour-stem-like cell niche. CSCs and endothelial precursor
cells are cooperating closely in the vascular/cancer stem niche. Cell-
to-cell cross-talk operates through chemokines such as CCL17,
CCL21, CCL27, and CXCL12, regulating EPCs migration and tumour
cells escape. Similarly, microRNAs mediate the EC-to-CSCs cross-
talk, because they act on cells by regulating gene expression.
Hypoxa-miRs, induced under hypoxia, act on angiogenesis either
directly or by action on angiomiRs [33]. In tumours, miR-210, is HIF-
1a-dependent and helps its stabilization, thus controlling the
hypoxic phenotype. The designed 3D tumour model established
both HIF-1a and miR-210 production under normoxic externalconditions, corroborating the setting of hypoxia inside such 3D
structures [40,41] and their stabilization under prolonged hypoxic
external conditions [40]. Among other hypoxa-miRs and angiomiRs
miR-21 which induces angiogenesis through AKT activation and
targets PTEN [42], is increased in ECs in hypoxia growing spheroids.
MiR-29b which has many effects on cancer evolution working as a
tumour suppressor [43], consistently decreased in all cell pop-
ulations in spheroids and in response to hypoxia. MiR-1246, which
controls angiogenesis in cancer [23], increased in all cells of the 3D
tumour model especially in hypoxia as opposed to its decrease in
2D cultured cells. Thus, our data point to the importance of utilizing
cell culture methods that provide access to the tumour microen-
vironment. Indeed, in standard 2D cultures in hypoxia the
expression of miR-21 and miR-1246 decreased compared to the
control in normoxia, and the expression of the miR-21 was highly
elevated in the 3D tumour model, and this effect was considerably
greater for the miR-1246 expression in all cell populations that
composed the tumour 3D models. Thus, although 2D cultures
showed that hypoxia influences the cell response by the modula-
tion of miR expression, the use of tridimensional tumour models, in
which the cellular and molecular components that contribute to
the tumour tissue development, are taken into account, appears of
fundamental importance. The miR response illustrates this effect,
as it appears in the 3D models to be different or even opposite to
the response obtained in 2D. This response in 3D conditions is in
agreement with in vivo reported data. The designed 3D tumour
models make it possible to study, in vitro, the fine-tuning of the
microenvironment processes like tumour-angiogenesis. It un-
derlines the key role of tumour hypoxia in the selection of tumour
stem cells and their action in specifically recruiting early endo-
thelial progenitors. Our observations point clearly to the weakness
of classical 2D cell culture methods in normoxia and the risk of
providing biologically irrelevant data. They provide a newmeans to
approach the mechanism of vessels formation in tumours and to
evidence interactions inside the tumour site. Despite limitations
inherent to in vitro simplifications, the designed 3D spheroid
tumour model makes a step forward in the reconstitution of
tumour pathology.
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